Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
Status:
Not yet recruiting
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
The overall primary objective of the PULSE-MI trial is to test the hypothesis that
administration of single-dose glucocorticoid pulse therapy in the pre-hospital setting
reduces final infarct size in patients with ST-segment elevation myocardial infarction
(STEMI) treated with primary percutaneous coronary intervention (PCI)